ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Pfizer receives positive CHMP opinion for Trumenba for prevention of meningococcal group B disease
March 28, 2017Pfizer announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending that Trumenba (Meningococcal Group B Vaccine) be granted marketing authorization in the European Union
Pharma Sources Insight January 2025
